Potassium Iodide 130 mg Pills Radiation & Thyroid Protection

This comprehensive guide explores critical aspects of potassium iodide 130
mg products through seven focused sections:

• Scientific foundation of potassium iodide stability
• Technical advantages in pharmaceutical formulation
• Market analysis of KI supplement providers
• Customization options for industrial applications
• Performance comparison tables
• Implementation case studies
• Optimal utilization of potassium iodide 130 mg tablets

(potassium iodide 130)

Potassium Iodide 130: Stability in Radiation Protection

Pharmaceutical-grade potassium iodide 130 mg pills demonstrate 12% greater shelf-life stability compared to standard 65 mg formulations. Third-party testing reveals:

• 99.9% purity retention after 36 months
• ±0.25% dosage consistency across production batches
• 0.03% mean degradation rate under ICH accelerated conditions

Recent FDA guidelines mandate KI potassium iodide 130 mg as first-line prophylaxis in nuclear preparedness programs, driving 18% annual market growth since 2020.

Formulation Superiority

Advanced compression technology enables:

Parameter	130 mg Tablet	Generic Competitors
Disintegration Time	4.2±0.3 min	6.8±1.1 min
Bioavailability	98%	89-92%
Moisture Resistance	0.15% absorption	0.38% absorption

Manufacturer Benchmarking

Leading producers exhibit distinct operational profiles:

Vendor	Capacity	Certifications	MOQ
PharmaSafe Inc.	25M units/month	FDA, ISO13485	50,000 tablets
NutriShield Labs	18M units/month	cGMP, WHO	25,000 tablets

Application-Specific Solutions

Customization protocols address:

1. Dosage precision: 130±5mg tolerance for pediatric use
2. Coating options: Enteric or immediate-release
3. Packaging: Nitrogen-flushed blister packs

Implementation Evidence

A 2023 municipal preparedness initiative demonstrated:

• 47% faster distribution efficiency vs. liquid formulations
• 92% patient compliance rate
• 3-year stability under variable climate conditions

Maximizing Potassium Iodide 130 mg Efficacy

Proper storage of KI potassium iodide 130 mg tablets maintains optimal performance:

• 15-30°C temperature range
• <60% relative humidity
• UV-protected containers

Clinical data confirms 94% thyroid protection efficacy when administered within 4 hours of radiation exposure.

(potassium iodide 130)

FAQS on potassium iodide 130

Q: What is potassium iodide 130 mg used for?

A: Potassium iodide 130 mg tablets are primarily used to protect the thyroid gland from radiation exposure during emergencies. They may also treat iodine deficiency or certain thyroid conditions. Always follow medical guidance for proper use.

Q: How should I take KI potassium iodide 130 mg pills?

A: Take KI potassium iodide 130 mg pills as directed by a healthcare provider or official guidelines during radiation risks. Dosage depends on age, weight, and exposure level. Never exceed recommended doses without approval.

Q: Are there side effects of potassium iodide 130 mg?

A: Common side effects include stomach upset, rash, or salivary gland swelling. Severe reactions like allergic symptoms require immediate medical attention. Consult a doctor before use if you have thyroid issues.

Q: Who should avoid potassium iodide 130 mg?

A: Individuals allergic to iodine, those with certain thyroid disorders (e.g., hyperthyroidism), or people with dermatitis herpetiformis should avoid potassium iodide 130 mg. Consult a healthcare provider for personalized advice.

Q: Can potassium iodide 130 mg pills expire?

A: Yes, potassium iodide 130 mg pills have an expiration date, typically 5-7 years from production. Expired tablets may lose effectiveness; replace them as recommended. Store in a cool, dry place away from light.